Frontier Medicines Announces Advancement of First Program Under Global Partnership with AbbVie

NEXT STORY
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
PREV STORY
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sarepta Therapeutics Announces First Quarter 2020 Financial Results and Recent Corporate Developments

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Proposed Public Offering of ADSs

author_avatar
NASDAQ Market News

Dermavant Appoints Chris Chapman as Chief Commercial Officer

author_avatar
NASDAQ Market News